[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ANIP":3,"homepage-market-summary":30,"stock-news-ANIP":173},{"ticker":4,"date":5,"profile":6,"quote":14},"ANIP","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"ANI Pharmaceuticals, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.","970","Princeton, NJ",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},72.18,73.16,73.27,71.73,72.96,-0.78,-1.07,300033.153897,7721,72.1902,450,4.8,104602.24526980455,15.1,6641,{"status":31,"indices":32,"watchlist":77,"sectors":99,"benchmarks":155},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":75,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,false,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":39,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":39,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":39,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":39},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":39},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":75},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":39},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":39},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":39},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},13,[176,182,188,194,200,206,212,218,224,230,235,240,245],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1gFBVV95cUxQWTdSdm50eHlUTTJaTVJvaFhuWXVVUG5NVWZnREtYYTZzczhzLVFOYmxFckZybXVQRW4zNXp4dzFoOXhvN1dPTE1pckhqdGlqQVZNYy1KZGlOUzEtYW1xTG5EVWpUc2JMa1diNFE1bDZjZVFQV1V4cURkQS1hSnVteTB2d1RxbF9zUHBsVVJNQW44TkR1aDAzQkNlbVUxeUVWbnc4QlVWT1djbi1PVkVJY09LWVYxUUctQjRONHFDeTZHeWhzSGZLcUJyV05oQTBWZVo0dDNB?oc=5","Wed, 30 Sep 2026 21:14:51 GMT","ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares MarketBeat","MarketBeat",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisAFBVV95cUxNZGctOXJtLVIySkd6bk4wWEk2dHRoVkYtV0pFWTlSQjRQekJ4djBVTnA2N2VYcFk3WmFZaG1OcUZVOExTb0dkUWFuandmQVVVWUpwdVRMQTJzWnV0Ym9iaFZDbi0yT2NIQzl6aE1kZEd3VVB6Ul9nUXU2U29KaG05UnFYbWg3QXROYW55bmQyd080Tl9xa05aX0EwdTk4N3d4YjJ1azNsNVZzWUtpU21rUQ?oc=5","Wed, 30 Sep 2026 10:55:00 GMT","Data on an eye implant for chronic eye inflammation will be presented in a late-breaking talk Oct. 9. Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Understanding Momentum Shifts in (ANIP) - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxPeDZ5cXFRNWlYSFVrZnA4dEVrT3dZU09udUVtaVBPZEtfbGxkQ0p5azB2U2gwX2l1TWhfUjdUWUZ2X0l2M3JYd3lxX1hSNlcyXzhPUVNZY0M3aWdSUmh5cmw4dTdvekhTdml6MlZvY3JGYVY3dUlyWEJ3QkZBS3dMZGd1Mm9nZ1Q2MUNRbWg0OUhoYVBpbmdLNUZKRG5IZmlZcXZQN1NNS2c1dWRHWkladzNSVXVhZVE?oc=5","Wed, 30 Sep 2026 04:52:02 GMT","Understanding Momentum Shifts in (ANIP) Stock Traders Daily","Stock Traders Daily",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikwFBVV95cUxPblhWSEl4LTlOWndwWmpxLXBpT3Q0YWxHOWU0OFppZGpzbXVvOXZPMXhtQ2dpbXJFWE5EVUpnVDJlaU1zLU1vX2tZUUN3MkMyUEljT3RPOHY5bTRHTkVwTTI5akJ5c1dPem93SjY1djRtSjF3SkMwU1E4bFEtaDVsaU93TklETnZ2clB3WFBNSFpzSzQ?oc=5","Thu, 01 Oct 2026 03:50:25 GMT","ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"1 Small-Cap Stock for Long-Term Investors and 2 We Ignore - StockStory","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNb0h1bHBYbHQ0c0w0Z0hyRndDazRQR0NRcVZ1Tkh2bnA4QXMzcEdEdlVNalI1anpVSjlPX2plWEdNUm5ENjNpZUZVVkt5MG9PX2J6THdpWEVmSkhBTG5LUU5jaEJIdGIxUFB3WGRaT3RPNUJ1RHNuSktDdGV6YWllcHRCYXlocmpyUkpZbHdrVkIyQVp5cnJaY3p3Q2wtRE1Yd0dCdUdLUWxmNHYyQ1loT2dqVFRMTWVXa3FZ?oc=5","Thu, 01 Oct 2026 09:50:34 GMT","1 Small-Cap Stock for Long-Term Investors and 2 We Ignore StockStory","StockStory",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxNeWdUUXFMSlZtdjM1NFBxSEJCNGJCRmZUcW1PSG50bUMyTjBWWDJ2alpGWDN3eGJsSUYtcU1MaDZoUkpLcmFQMzNvZU5BU2NsQWdnZmNOY2lFRVFqNURRUElYN1VUSHJjZVp0UkthRmpNMjRJQ3MweXJaempkLVVIQ1hjVnRxbnV5SVdwenhhZmVDbVliWUZBR25hMHNfQnV4QldNaWRtOUR2eDlOeER6d2lB?oc=5","Thu, 24 Sep 2026 16:15:31 GMT","ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) Seeking Alpha","Seeking Alpha",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQNldtRzBOb0lYTTdBYjlwOHNnd0NmOEFWX2pWUmxETGs5dkxQdUxmdDZwYmduWU5DRl9WX3EyZkhOLVp0WjF3aG4zVDZpQVFubHdUdGd4RzFHNTVEWERUMGhTZ21oUllFMC14dFp6QVI1NFhlcDA2NjRqNkVuSlFIWWM4bjd4RGYxMm1XdHZ6bXAxcFBmZHRHUGVzZzFSRE9udFVCenZfVEdYcm1DVlltMFpZQ25HRGNXckd5UEptZTA2OHc?oc=5","Wed, 23 Sep 2026 11:00:00 GMT","ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension Quiver Quantitative","Quiver Quantitative",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Should FDA Generic Everolimus Approval Require Action From ANI Pharmaceuticals (ANIP) Investors? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 23 Sep 2026 16:49:52 GMT","Should FDA Generic Everolimus Approval Require Action From ANI Pharmaceuticals (ANIP) Investors? Simply Wall Street","Simply Wall Street",{"title":225,"link":226,"pubDate":227,"description":228,"source":229},"Implied Volatility Surging for ANI Pharmaceuticals Stock Options - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNWVJKZVI2ckdYV29jbjZzMTVKdDZqSjlpN3FGS3JrMThCRmcwZG9TeFBidWxRWFQ1OHJneVloMDJfV1RRMVBXSTdITEVXRVYzSU1yeFFXQnFFX3VWV0lVdmtfS3MwS2JwckhjNl9ZdmJOR3VZR0pJNTJjWnd1RDRYOWZNQm9wTmRtTFNWTlVxWUZPa1dDNGFnUk5ZaGcyS1hlR2RIRnd0cUJHdEhPdEhNeEVaQUM0NmhaNmQw?oc=5","Mon, 28 Sep 2026 14:41:00 GMT","Implied Volatility Surging for ANI Pharmaceuticals Stock Options TradingView","TradingView",{"title":231,"link":232,"pubDate":233,"description":234,"source":187},"After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOXzNWbDFvN1BYRWZkSU9OakhQUVBseWFHQ0h1a1FlUkpNbExXU0tpdVZLSzdPQ2M0bzVZTnBhTTBMLUFNd1NEclBhMmJnR0xRSk43YUJnZldKbmthdjM0c3RmcmZlMHZEaHNfbVo2Mlc0NWRxYWgteUo3d09ENVhmeFoxeUJfbnF4QXZxUUNLVWlSRm1CNU5YZWZSYWl4NWZVZ05ib0RPamVoY0t5dGhkTENpOWdyOEwt?oc=5","Wed, 30 Sep 2026 20:52:30 GMT","After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. Stock Titan",{"title":236,"link":237,"pubDate":238,"description":239,"source":181},"183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2gFBVV95cUxQZGRPTlhJRDV6bXRuLVRkMnJJMUM0UHg0WGRkOXp6ampneHJhZ3dER29lZ1BOZEMtRV9xMXV1MXBGSUtnUjM1cEVtNHUxXzcxYThRQ0xoZDZ3N1RzQTNEVzZsbmlYMDRPZHdScTVfUUlmdUppNWJhQjRKR0xNS2NuZUZvRnpKY0ljWkxwLXY1bi0tSmV2T0ZwUE5rUHdqVDJkUkNxbkQ2dzl0c2pWYlZ5NDI5OEZOUlZQVkZtbUhnS1I4RHFzdXlJNmxFSnFLRUFVRWxsblVUcWVYQQ?oc=5","Sat, 26 Sep 2026 07:08:45 GMT","183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE MarketBeat",{"title":241,"link":242,"pubDate":243,"description":244,"source":223},"ANI Pharmaceuticals (ANIP) FDA Approval Puts Fair Value Back In Focus - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 29 Sep 2026 14:32:32 GMT","ANI Pharmaceuticals (ANIP) FDA Approval Puts Fair Value Back In Focus Simply Wall Street",{"title":246,"link":247,"pubDate":248,"description":249,"source":250},"3 Profitable Stocks Worth Investigating - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPZUduQ0ZIZnBJLWItWGIwQ1JTMUFRQ1hVNEVIdWZQWFM5TC03TEUwSnVyWXZwNHJJaTZDYkFseldjZENqSzhXdFQ1RUJhT0pQc0RpeU5SUDJIekpPQ0NyVXJ2TW1BSUlqRjlkZzd5VFBYSHctc3VRdC1hSmpHMHVhYlBLeTc3YkNIcjZBTWlOd3lCaGNoSTlzNmJHdHB1YW5Cd1RNTEREbDZTaktNUHIxVEhrdnpGWDY4UzhGa0t4Yl9MZw?oc=5","Tue, 29 Sep 2026 04:36:00 GMT","3 Profitable Stocks Worth Investigating The Globe and Mail","The Globe and Mail"]